{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T23:08:33Z","timestamp":1768518513354,"version":"3.49.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,2,15]],"date-time":"2018-02-15T00:00:00Z","timestamp":1518652800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s00296-018-3993-5","type":"journal-article","created":{"date-parts":[[2018,2,15]],"date-time":"2018-02-15T15:46:02Z","timestamp":1518709562000},"page":"879-885","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Canakinumab treatment in children with familial Mediterranean fever: report from a single center"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6483-8978","authenticated-orcid":false,"given":"Fatma","family":"Yaz\u0131l\u0131ta\u015f","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3117-5968","authenticated-orcid":false,"given":"\u00d6zlem","family":"Aydo\u011f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9609-1511","authenticated-orcid":false,"given":"Sare G\u00fclfem","family":"\u00d6zl\u00fc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1697-6206","authenticated-orcid":false,"given":"Evrim Karg\u0131n","family":"\u00c7ak\u0131c\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5881-1565","authenticated-orcid":false,"given":"T\u00fclin","family":"G\u00fcng\u00f6r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2364-4282","authenticated-orcid":false,"given":"Fehime Kara","family":"Ero\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5851-8676","authenticated-orcid":false,"given":"G\u00f6k\u00e7e","family":"G\u00fcr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9007-9653","authenticated-orcid":false,"given":"Mehmet","family":"B\u00fclb\u00fcl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,15]]},"reference":[{"issue":"3","key":"3993_CR1","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nrrheum.2013.174","volume":"10","author":"S Ozen","year":"2014","unstructured":"Ozen S, Bilginer Y (2014) A clinical guide to autoinflammatory diseases: familial Mediterranean fever and next-of-kin. Nat Rev Rheumatol 10(3):135\u2013147. https:\/\/doi.org\/10.1038\/nrrheum.2013.174","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"3993_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.5152\/eurjrheum.2014.006","volume":"1","author":"I Sar\u0131","year":"2014","unstructured":"Sar\u0131 I, Birlik M, Kasifo\u011flu T (2014) Familial Mediterranean fever: an updated review. Eur J Rheumatol 1(1):21\u201333","journal-title":"Eur J Rheumatol"},{"issue":"1","key":"3993_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/ng0997-25","volume":"17","author":"FMF French","year":"1997","unstructured":"French FMF Consortium (1997) A candidate gene for familial Mediterranean fever. Nat Genet 17(1):25\u201331","journal-title":"Nat Genet"},{"issue":"4","key":"3993_CR4","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S0092-8674(00)80539-5","volume":"90","author":"The International FMF Consortium","year":"1997","unstructured":"The International FMF Consortium (1997) Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 90(4):797\u2013807","journal-title":"Cell"},{"issue":"5","key":"3993_CR5","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1182\/blood-2008-01-134932","volume":"112","author":"JJ Chae","year":"2008","unstructured":"Chae JJ, Wood G, Richard K, Jaffe H, Colburn NT, Masters SL et al (2008) The familial Mediterranean fever protein, pyrin, is cleaved by caspase-1 and activates NF-kappaB through its N-terminal fragment. Blood 1 112(5):1794\u20131803. https:\/\/doi.org\/10.1182\/blood-2008-01-134932","journal-title":"Blood 1"},{"issue":"6","key":"3993_CR6","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1182\/blood.V87.6.2095.bloodjournal8762095","volume":"15","author":"CA Dinarello","year":"1996","unstructured":"Dinarello CA (1996) Biologic basis for interleukin-1 in disease. Blood 15(6):2095\u20132147 (2187)","journal-title":"Blood"},{"key":"3993_CR7","doi-asserted-by":"publisher","first-page":"893507","DOI":"10.1155\/2015\/893507","volume":"2015","author":"Y Bozkurt","year":"2015","unstructured":"Bozkurt Y, Demir A, Erman B, G\u00fcl A (2015) Unified modeling of familial Mediterranean fever and cryopyrin associated periodic syndromes. Comput Math Methods Med 2015:893507. https:\/\/doi.org\/10.1155\/2015\/893507","journal-title":"Comput Math Methods Med"},{"issue":"5","key":"3993_CR8","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/j.1365-2141.2009.07733.x","volume":"146","author":"JJ Chae","year":"2009","unstructured":"Chae JJ, Aksentijevich I, Kastner DL (2009) Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapy. Br J Haematol 146(5):467\u2013478. https:\/\/doi.org\/10.1111\/j.1365-2141.2009.07733.x","journal-title":"Br J Haematol"},{"key":"3993_CR9","doi-asserted-by":"publisher","first-page":"248","DOI":"10.4172\/2157-7412.1000248","volume":"5","author":"DQH Wang","year":"2014","unstructured":"Wang DQH, Bonfrate L, de Bari O, Wang TY, Portincasa P (2014) Familial Mediterranean fever: from pathogenesis to treatment. J Genet Syndr Gene Ther 5:248. https:\/\/doi.org\/10.4172\/2157-7412.1000248","journal-title":"J Genet Syndr Gene Ther"},{"issue":"Pt 5","key":"3993_CR10","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1242\/jcs.03377","volume":"120","author":"D Brough","year":"2007","unstructured":"Brough D, Rothwell NJ (2007) Caspase-1-dependent processing of pro-interleukin-1 beta is cytosolic and precedes cell death. J Cell Sci 1 120 (Pt 5):772\u2013781","journal-title":"J Cell Sci 1"},{"issue":"5","key":"3993_CR11","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1097\/bor.0000174210.78449.6b","volume":"17","author":"S Stojanov","year":"2005","unstructured":"Stojanov S, Kastner DL (2005) Familial autoinflammatory diseases: genetics, pathogenesis and treatment. Curr Opin Rheumatol 17(5):586\u2013599","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"3993_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/clpt.2013.148","volume":"95","author":"I Grattagliano","year":"2014","unstructured":"Grattagliano I, Bonfrate L, Ruggiero V, Scaccianoce G, Palasciano G, Portincasa P (2014) Novel therapeutics for the treatment of familial mediterranean fever: from colchicine to biologics. Clin Pharmacol Ther 95(1):89\u201397","journal-title":"Clin Pharmacol Ther"},{"issue":"8","key":"3993_CR13","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1007\/s00467-011-1797-x","volume":"26","author":"Y Bilginer","year":"2011","unstructured":"Bilginer Y, Akpolat T, Ozen S (2011) Renal amyloidosis in children. Pediatr Nephrol 26(8):1215\u20131227. https:\/\/doi.org\/10.1007\/s00467-011-1797-x","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"3993_CR14","first-page":"509","volume":"21","author":"A Duzova","year":"2003","unstructured":"Duzova A, Bakkaloglu A, Besbas N, Topaloglu R, Ozen S, Ozaltin F et al (2003) Role of A-SAA in monitoring subclinical inflammation and in colchicine dosage in familial Mediterranean fever. Clin Exp Rheum 21(4):509\u2013514","journal-title":"Clin Exp Rheum"},{"issue":"11","key":"3993_CR15","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1136\/ard.2007.071498","volume":"66","author":"LM Kuijk","year":"2007","unstructured":"Kuijk LM, Govers AM, Frenkel J, Hofhuis WJ (2007) Effective treatment of a colchicineresistant familial Mediterranean fever patient with anakinra. Ann Rheum Dis 66(11):1545\u20131546","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"3993_CR16","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.semarthrit.2010.11.003","volume":"41","author":"U Meinzer","year":"2011","unstructured":"Meinzer U, Quartier P, Alexandra JF, Hentgen V, Retornaz F, Kon\u00e9-Paut I (2011) Interleukin-1 targeting drugs in familial Mediterranean fever: a case series and a review of the literature. Semin Arthritis Rheum 41(2):265\u2013271. https:\/\/doi.org\/10.1016\/j.semarthrit.2010.11.003","journal-title":"Semin Arthritis Rheum"},{"issue":"10","key":"3993_CR17","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1007\/s00296-015-3293-2","volume":"35","author":"FK Eroglu","year":"2015","unstructured":"Eroglu FK, Be\u015fba\u015f N, Topaloglu R, Ozen S (2015) Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents. Rheumatol Int 35(10):1733\u20131737. https:\/\/doi.org\/10.1007\/s00296-015-3293-2","journal-title":"Rheumatol Int"},{"issue":"11","key":"3993_CR18","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1080\/14712598.2016.1233963","volume":"16","author":"R Haviv","year":"2016","unstructured":"Haviv R, Hashkes PJ (2016) Canakinumab investigated for treating familial Mediterranean fever. Expert Opin Biol Ther 16(11):1425\u20131434","journal-title":"Expert Opin Biol Ther"},{"issue":"7","key":"3993_CR19","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1136\/ard.2010.146878","volume":"70","author":"I Mitroulis","year":"2011","unstructured":"Mitroulis I, Skendros P, Oikonomou A, Tzioufas AG, Ritis K (2011) The efficacy of canakinumab in the treatment of a patient with familial Mediterranean fever and long standing destructive arthritis. Ann Rheum Dis 70(7):1347\u20131348. https:\/\/doi.org\/10.1136\/ard.2010.146878","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"3993_CR20","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s10067-014-2772-2","volume":"35","author":"ZB \u00d6z\u00e7akar","year":"2016","unstructured":"\u00d6z\u00e7akar ZB, \u00d6zdel S, Y\u0131lmaz S, Kurt-\u015e\u00fck\u00fcr ED, Ekim M, Yal\u00e7\u0131nkaya F (2016) Anti-IL-1 treatment in familial Mediterranean fever and related amyloidosis. Clin Rheumatol 35(2):441\u2013446. https:\/\/doi.org\/10.1007\/s10067-014-2772-2","journal-title":"Clin Rheumatol"},{"issue":"1","key":"3993_CR21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40348-016-0058-2","volume":"3","author":"B Sozeri","year":"2016","unstructured":"Sozeri B, Gulez N, Ergin M, Serdaroglu E (2016) The experience of canakinumab in renal amyloidosis secondary to familial Mediterranean fever. Mol Cell Pediatr 3(1):33. https:\/\/doi.org\/10.1186\/s40348-016-0058-2","journal-title":"Mol Cell Pediatr"},{"issue":"4","key":"3993_CR22","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s00467-015-3249-5","volume":"31","author":"R Topaloglu","year":"2016","unstructured":"Topaloglu R, Batu ED, Orhan D, Ozen S, Besbas N (2016) Anti-interleukin 1 treatment in secondary amyloidosis associated with autoinflammatory diseases. Pediatr Nephrol 31(4):633\u2013640. https:\/\/doi.org\/10.1007\/s00467-015-3249-5","journal-title":"Pediatr Nephrol"},{"issue":"7","key":"3993_CR23","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1007\/s10067-013-2481-2","volume":"34","author":"R Scarpioni","year":"2015","unstructured":"Scarpioni R, Rigante D, Cantarini L, Ricardi M, Albertazzi V, Melfa L et al (2015) Renal involvement in secondary amyloidosis of Muckle\u2013Wells syndrome: marked improvement of renal function and reduction of proteinuria after therapy with human anti-interleukin-1\u03b2 monoclonal antibody canakinumab. Clin Rheumatol 34(7):1311\u20131316. https:\/\/doi.org\/10.1007\/s10067-013-2481-2","journal-title":"Clin Rheumatol"},{"issue":"10","key":"3993_CR24","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1002\/art.1780401023","volume":"40","author":"A Livneh","year":"1997","unstructured":"Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T et al (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40(10):1879\u20131885","journal-title":"Arthritis Rheum"},{"issue":"1","key":"3993_CR25","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.semarthrit.2017.03.006","volume":"47","author":"S Ozen","year":"2017","unstructured":"Ozen S, Kone-Paut I, G\u00fcl A (2017) Colchicine resistance and intolerance in familial mediterranean fever: definition, causes, and alternative treatments. Semin Arthritis Rheum 47(1):115\u2013120. https:\/\/doi.org\/10.1016\/j.semarthrit.2017.03.006","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"3993_CR26","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1053\/S0049-0172(03)00137-9","volume":"33","author":"M Lidar","year":"2004","unstructured":"Lidar M, Scherrmann JM, Shinar Y, Chetrit A, Niel E, Gershoni-Baruch R et al (2004) Colchicine nonresponsiveness in familial Mediterranean fever: clinical, genetic, pharmacokinetic, and socioeconomic characterization. Semin Arthritis Rheum 33(4):273\u2013282","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"3993_CR27","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1136\/annrheumdis-2013-204719","volume":"73","author":"S Ozen","year":"2014","unstructured":"Ozen S, Demirkaya E, Duzova A, Erdogan O, Erken E, Gul A et al (2014) FMF50: a score for assessing outcome in familial Mediterranean fever. FMF Arthritis Vasculitis and Orphan disease Research in pediatric rheumatology (FAVOR) and Turkish FMF study group. Ann Rheum Dis 73(5):897\u2013901. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204719","journal-title":"Ann Rheum Dis"},{"issue":"5 Suppl 24","key":"3993_CR28","first-page":"S63","volume":"19","author":"N Cakar","year":"2001","unstructured":"Cakar N, Yal\u00e7inkaya F, Ozkaya N, Tekin M, Akar N, Ko\u00e7ak H et al (2001) Familial Mediterranean fever (FMF)-associated amyloidosis in childhood. Clinical features, course and outcome. Clin Exp Rheumatol 19(5 Suppl 24):S63\u2013S67","journal-title":"Clin Exp Rheumatol"},{"issue":"16","key":"3993_CR29","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1056\/NEJM198604173141601","volume":"314","author":"D Zemer","year":"1986","unstructured":"Zemer D, Pras M, Sohar E, Modan M, Cabili S, Gafni J (1986) Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med 314(16):1001\u20131005. https:\/\/doi.org\/10.1056\/nejm198604173141601","journal-title":"N Engl J Med"},{"key":"3993_CR30","unstructured":"Shohat M (2000) In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mefford HC, Stephens K, Amemiya A, Ledbetter N (eds) GeneReviews\u00ae (internet), 1993\u20132017. University of Washington, Seattle (updated 15 Dec 2016)"},{"issue":"1","key":"3993_CR31","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3899\/jrheum.090273","volume":"37","author":"O Soylemezoglu","year":"2010","unstructured":"Soylemezoglu O, Arga M, Fidan K, Gonen S, Emeksiz HC, Hasanoglu E et al (2010) Unresponsiveness to colchicine therapy in patients with familial Mediterranean fever homozygous for the M694V mutation. J Rheumatol 37(1):182\u2013189. https:\/\/doi.org\/10.3899\/jrheum.090273","journal-title":"J Rheumatol"},{"issue":"4","key":"3993_CR32","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1136\/annrheumdis-2015-208690","volume":"75","author":"S Ozen","year":"2016","unstructured":"Ozen S, Demirkaya E, Erer B, Livneh A, Ben-Chetrit E, Giancane G et al (2016) EULAR recommendations for the management of familial Mediterranean fever. Ann Rheum Dis 75(4):644\u2013651. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208690","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"3993_CR33","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1136\/annrheumdis-2012-202774","volume":"73","author":"A Omenetti","year":"2014","unstructured":"Omenetti A, Carta S, Delfino L, Martini A, Gattorno M, Rubartelli A (2014) Increased NLRP3-dependent interleukin 1\u03b2 secretion in patients with familial Mediterranean fever: correlation with MEFV genotype. Ann Rheum Dis 73(2):462\u2013469. https:\/\/doi.org\/10.1136\/annrheumdis-2012-202774","journal-title":"Ann Rheum Dis"},{"issue":"4 Suppl 67","key":"3993_CR34","first-page":"S87","volume":"29","author":"F Yalcinkaya","year":"2011","unstructured":"Yalcinkaya F, Ozcakar ZB, Tanyildiz M, Elhan AH (2011) Familial Mediterranean fever in small children in Turkey. Clin Exp Rheumatol 29(4 Suppl 67):S87\u2013S90","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"3993_CR35","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s10067-009-1279-8","volume":"29","author":"Y Bilginer","year":"2010","unstructured":"Bilginer Y, Ayaz NA, Ozen S (2010) Anti-IL-1 treatment for secondary amyloidosis in an adolescent with FMF and Beh\u00e7et\u2019s disease. Clin Rheumatol. 29(2):209\u2013210. https:\/\/doi.org\/10.1007\/s10067-009-1279-8","journal-title":"Clin Rheumatol"},{"issue":"4","key":"3993_CR36","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3109\/14397595.2014.987437","volume":"25","author":"\u00d6 Ba\u015faran","year":"2015","unstructured":"Ba\u015faran \u00d6, Uncu N, \u00c7elikel BA, Taktak A, G\u00fcr G, Cakar N (2015) Interleukin-1 targeting treatment in familial Mediterranean fever: an experience of pediatric patients. Mod Rheumatol 25(4):621\u2013624. https:\/\/doi.org\/10.3109\/14397595.2014.987437","journal-title":"Mod Rheumatol"},{"issue":"5","key":"3993_CR37","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1080\/1744666X.2017.1313116","volume":"13","author":"H Ozdogan","year":"2017","unstructured":"Ozdogan H, Ugurlu S (2017) Canakinumab for the treatment of familial Mediterranean fever. Expert Rev Clin Immunol 13(5):393\u2013404. https:\/\/doi.org\/10.1080\/1744666X.2017.1313116","journal-title":"Expert Rev Clin Immunol"},{"issue":"11","key":"3993_CR38","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.1002\/art.38777","volume":"66","author":"R Brik","year":"2014","unstructured":"Brik R, Butbul-Aviel Y, Lubin S, Ben Dayan E, Rachmilewitz-Minei T, Tseng L et al (2014) Canakinumab for the treatment of children with colchicine-resistant familial Mediterranean fever: a 6-month open-label, single-arm pilot study (Hoboken, NJ). Arthritis Rheumatol (Hoboken NJ) 66(11):3241\u20133243. https:\/\/doi.org\/10.1002\/art.38777","journal-title":"Arthritis Rheumatol (Hoboken NJ)"},{"issue":"6","key":"3993_CR39","first-page":"945","volume":"67","author":"S Ozkan","year":"2017","unstructured":"Ozkan S, Atas B (2017) Canakinumab treatment in four children with colchicine resistant familial mediterranean fever. J Pak Med Assoc 67(6):945\u2013947","journal-title":"J Pak Med Assoc"},{"key":"3993_CR40","doi-asserted-by":"publisher","unstructured":"G\u00fcl A, Ozdogan H, Erer B, Ugurlu S, Kasapcopur O, Davis N, Sevgi S. Efficacy and safety of canakinumab in adolescents and adults with colchicine-resistant familial Mediterranean fever. Arthritis Res Ther 17:243. https:\/\/doi.org\/10.1186\/s13075-015-0765-4","DOI":"10.1186\/s13075-015-0765-4"},{"key":"3993_CR41","doi-asserted-by":"publisher","first-page":"238931","DOI":"10.1155\/2014\/238931","volume":"2014","author":"F Salehzadeh","year":"2014","unstructured":"Salehzadeh F, Yasrebi O, Hosseini Khotbesara M, Hosseini Khotbesara M (2014) Idiopathic uveitis and familial Mediterranean fever: is there any relationship? Autoimmune Dis 2014:238931. https:\/\/doi.org\/10.1155\/2014\/238931","journal-title":"Autoimmune Dis"},{"key":"3993_CR42","unstructured":"Berestizschevsky S, Weinberger D, Avisar I, Avisar R. Episcleritis associated with familial Mediterranean fever. Isr Med Assoc J 10(4):318\u2013319"},{"issue":"7","key":"3993_CR43","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1007\/s10067-013-2443-8","volume":"34","author":"L Cantarini","year":"2015","unstructured":"Cantarini L, Vitale A, Scalini P, Dinarello CA, Rigante D, Franceschini R et al (2015) Anakinra treatment in drug-resistant Behcet\u2019s disease: a case series. Clin Rheumatol 34(7):1293\u20131301. https:\/\/doi.org\/10.1007\/s10067-013-2443-8","journal-title":"Clin Rheumatol"},{"issue":"9","key":"3993_CR44","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1136\/annrheumdis-2012-201383","volume":"71","author":"S Ugurlu","year":"2012","unstructured":"Ugurlu S, Ucar D, Seyahi E, Hatemi G, Yurdakul S (2012) Canakinumab in a patient with juvenile Behcet\u2019s syndrome with refractory eye disease. Ann Rheum Dis 71(9):1589\u20131591. https:\/\/doi.org\/10.1136\/annrheumdis-2012-201383","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"3993_CR45","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s10067-016-3506-4","volume":"36","author":"C Fabiani","year":"2017","unstructured":"Fabiani C, Vitale A, Emmi G, Lopalco G, Vannozzi L, Guerriero S et al (2017) Interleukin (IL)-1 inhibition with anakinra and canakinumab in Beh\u00e7et\u2019s disease-related uveitis: a multicenter retrospective observational study. Clin Rheumatol 36(1):191\u2013197. https:\/\/doi.org\/10.1007\/s10067-016-3506-4","journal-title":"Clin Rheumatol"},{"issue":"7","key":"3993_CR46","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.3899\/jrheum.160064","volume":"43","author":"A Brambilla","year":"2016","unstructured":"Brambilla A, Caputo R, Cimaz R, Simonini G (2016) Canakinumab for childhood sightthreatening refractory uveitis: a case series. J Rheumatol 43(7):1445\u20131447. https:\/\/doi.org\/10.3899\/jrheum.160064","journal-title":"J Rheumatol"},{"issue":"1","key":"3993_CR47","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12348-015-0065-9","volume":"5","author":"M Hirano","year":"2015","unstructured":"Hirano M, Seguchi J, Yamamura M, Narita A, Okanobu H, Nishikomori R et al (2015) Successful resolution of stromal keratitis and uveitis using canakinumab in a patient with chronic infantile neurologic, cutaneous, and articular syndrome: a case study. J Ophthalmic Inflamm Infect 5(1):34. https:\/\/doi.org\/10.1186\/s12348-015-0065-9","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"2","key":"3993_CR48","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/art.37776","volume":"65","author":"G Simonini","year":"2013","unstructured":"Simonini G, Xu Z, Caputo R, De Libero C, Pagnini I, Pascual V et al (2013) Clinical and transcriptional response to the long-acting interleukin-1 blocker canakinumab in Blau syndrome-related uveitis. ArthritisRheum 65(2):513\u2013518. https:\/\/doi.org\/10.1002\/art.37776","journal-title":"ArthritisRheum"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-018-3993-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-018-3993-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-018-3993-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T05:40:44Z","timestamp":1603863644000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-018-3993-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,15]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["3993"],"URL":"https:\/\/doi.org\/10.1007\/s00296-018-3993-5","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,15]]},"assertion":[{"value":"20 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}